Content
All Posts > Content under Pharma/Biotech
Pot Stock Index Was Up 2.7% Wednesday; FSD Pharma Up 138% - Here's Why
Article By:
Lorimer Wilson
Read
Thursday, June 4, 2020 3:54 AM EDT
Major increases in FSD Pharma (+138.4%), Planet 13 (+26.2%), Pyxus Int'l (+16.1%) and Village Farms (+14.6%) were among the 25 of the 39 non-penny pot stocks going up yesterday.
Israeli Startup Deal Digest – May 2020
Article By:
Shelly Hod Moyal
Read
Wednesday, June 3, 2020 6:34 AM EDT
Here is last month's summary of corporate developments in the Israeli startup market. This May we tracked 28 announced deals totaling at approximately $582.5 Million, and 3 exits of $1.085 Billion.
In this article: INTC
Cannabis Central: Pot Stock Index Up 0.9% Tuesday; 5 Of 9 Categories Up
Article By:
Lorimer Wilson
Read
Wednesday, June 3, 2020 4:22 AM EDT
The Non-Penny Pot Stock Index (NPSI) was only up 0.9% on Tuesday with 20 of the 39 constituents having some minor gains and 18 showing some minor weakness (1 saw no change in price). 5 of the 9 sector categories advanced.
Cannabis Central: Only These 4 NPSI Constituents Moved 5% Or More On Monday
Article By:
Lorimer Wilson
Read
Tuesday, June 2, 2020 11:44 AM EDT
The Non-Penny Pot Stock Index (NPSI) was UP 1.8% on Monday with 20 of the 39 constituents having some minor gains and 15 showing some weakness (4 saw no change in price). 6 of the 9 sector categories advanced. The details are as follows.
AMERI Holdings Amalgamation Partner Jay Pharma Reports IRB Approval For Testing Proprietary CBD Formulation In Brain Cancer
Article By:
TalkMarkets Newswire
Read
Tuesday, June 2, 2020 9:35 AM EDT
Final approval is anticipated in summer 2020 to initiate phase I/II study in Glioblastoma Multiforme. The study will enroll 40 patients with recurrent or progressive GBM tumors who are currently undergoing chemotherapy.
In this article: AMRH
Cannabis Central: Sector Up Again In May Suggesting Turnaround Finally Happening
Article By:
Lorimer Wilson
Read
Monday, June 1, 2020 5:42 PM EDT
For the second month in a row the cannabis stock sector has advanced significantly (+10% in April and +19% in May) suggesting that the sector may have finally hit bottom at the end of March and is on the mend. Here are the details of the NPSI.
Making Sense Of Pandemic Valuations
Article By:
Karl Sjogren
Read
Monday, June 1, 2020 2:45 AM EDT
With the pandemic induced havoc, how is that the stock market is not down more? And what effect will the downturn have on the valuation of startups? This is the first of three articles that discuss valuations and capital structures.
Notable Insider Buys: Avis, Dynavax, And Formula One
Article By:
Benzinga
Read
Sunday, May 31, 2020 4:44 PM EDT
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason: they believe the stock price will rise and they want to profit from it. So, insider buying can be an encouraging signal for potential investors.
Karuna Schizophrenia Drug Has Blockbuster Potential, Says Stifel
Article By:
The Fly
Read
Sunday, May 31, 2020 1:41 PM EDT
The full Phase 2 data for KarXT, presented over the weekend by Karuna Therapeutics, show a schizophrenia drug that is at least as effective as the standard-of-care but via a totally new mechanism and has a "much improved" tolerability profile.
In this article: KRTX
US Stock Market Weekly Update May 25- May 29, 2020
Article By:
Stavros Georgiadis
Read
Sunday, May 31, 2020 7:02 AM EDT
A second consecutive week with gains for the US stock market, and another series of mostly negative economic news for the US economy, which did not harm the risk-on mood for stocks were the highlights during the last week of May 2020.
Market Breaks Above 200-DMA - Is The Bull Back?
Article By:
Lance Roberts
Read
Saturday, May 30, 2020 4:52 PM EDT
While the market broke above the 200-dma, it does not change the negative risk/reward characteristics of the market. on a longer-term basis, a deeper correction becomes more possible, given the deviation in prices from the underlying fundamentals.
Week In Review: Shenzhen's MGI Tech Raises $1 Billion To Develop Gene Sequencing Machines
Article By:
ChinaBio® Today
Read
Saturday, May 30, 2020 1:59 PM EDT
MGI Tech of Shenzhen, a company making gene-sequencing machines and related equipment, completed a $1 billion Series B round led by IDG Capital and CPE. Suzhou Kintor Pharma completed a $240 million IPO on the Hong Kong Exchange.
Cannabis ETF Tops In May: 5 Stocks That Led The Way
Article By:
Sweta Killa
Read
Friday, May 29, 2020 2:32 PM EDT
Though most of the stocks in the fund’s portfolio delivered strong returns, a few have gained more than 25%. Here are the five best-performing stocks in the ETF with their respective positions in the fund’s basket.
Cannabis Central: Volatility Evaporated Thursday; Only These 4 NPSI Constituents Moved 5% Or More
Article By:
Lorimer Wilson
Read
Friday, May 29, 2020 7:37 AM EDT
The Non-Penny Pot Stock Index (NPSI) was flat on Thursday up just 0.3% on the day. Columbia Care advanced the most (+12.2%) while FSD Pharma declined the most (-6.0%).
In this article: CGC, OGI, CCHWF (NOW CBSTF), HEXO, HUGE